California HF by Race/Ethnicity and Gender -Husaini et al discharged with a primary diagnosis of HF (ICD-9 codes 402, 404, 428). Numbers of HF cases were 58,544 in 2007 and 57,219 in 2010.
Data Characteristics
HDDS files are administrative files that provide patients' basic demographics such as: age; gender; county and zip code of residence; ICD-9 diagnostic codes (both primary and secondary diagnoses) for which a hospital in-patient was treated; race/ethnicity (White, Black, Hispanic/Latinos, Pacific Islanders/ Asians, Native American, and others); the number of admissions; days files. Hence, we focused on comparing HF rates, risk factors, and estimated costs across African American (Black), Hispanic, and White groups. Two indices of co-morbidity were computed: 1) a simple count of all secondary diagnoses for each patient; and 2) Charlson Index of co-morbidity, 25 which measures severity of co-morbidity for each patient. Since OSHPD files do not provide actual reimbursed dollars for services, we used the submitted charges as an estimated cost of HF for the year. We computed two types of hospital costs for the entire year: 1) costs/charges for HF alone (HF cost $), the amount associated with a patient discharged with HF as a primary diagnosis during the year; and 2) total hospital cost/charges for the year (Total cost $) that included HF cost plus the cost for the same patient when he/she was re-admitted with diagnoses other than HF. Physicians' charges were not included in the hospital costs/charges.
Statistical Analysis
Age-adjusted HF rates per 100,000 US adults (2010 Census) were developed per CDC methodology. 26 Additionally, we estimated age-specific prevalence for each age category (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) , 45-54, 55-64, 65-74, 75-84, and ≥85 years), gender, and age-specific prevalence ratios (PR) of HF for each sub-group. Differences in the prevalence of HF risk factors by gender, race/ethnicity and age were evaluated with the Pearson χ2 and the Fisher's Exact Tests. Group differences in cost and other continuous variables were examined by ANOVA or t-tests. To examine the likelihood of HF association with each risk factor, logistic models were used on the total sample first and then for each gender and race/ethnic sub-groups separately.
results

HF Rates and Changes in Rates (2007-2010) by Race/ Ethnicity and Gender
The mean age was 73 across both time periods and both periods included almost equal numbers of males and females; race/ethnicity breakdown was Blacks (14%), Hispanics (21%) and Whites (65%). Age differences at both times were statistically significant by race/ethnicity, whereby White patients (2010) were older (mean age + standard deviation = 76 ± 13.5 years), followed by Hispanics (69 ± 15.0 years) and Blacks (64 ± 15.3 years) ( Table 1 , columns 2,4,6). Similarly, rates for males were nearly 1.5:1 higher than female rates (Table 2, column 7) . Further, Blackto-White (B/W) rate ratios among the younger age category (≤54 years) remained higher, namely, 6:1 in both time periods ( in hospital; and charges (US$) for the stay. Only the attending physicians gave primary and secondary diagnoses. Secondary diagnoses were used as co-morbidities of HF.
While 12% of California's population is composed of Asians (eg, Chinese, Japanese, East Indians), no such data on ethnic sub-groups are available in the OSHPD administrative California HF by Race/Ethnicity and Gender -Husaini et al These ratios begin to decline at age 65 onwards. Similar trends emerged for younger adults (≤54) when Black-to Hispanic (B/H) rate ratios were examined (Table 2 , column 9). Here, younger Blacks (≤54) had significantly higher rates compared with Hispanics. Briefly, these data show that younger Blacks have higher HF hospitalization rates compared with their White and Hispanic peers. In contrast, Hispanic-to-White (H/W) ratios were different from those for B/W rate ratios. For example, the H/W ratios in 2007 were nearly 1:1 among Hispanics aged ≤45 years; in 2010 the ratios were slightly higher for each age group except in age group ≥85 years. 
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Hospital Costs by Race/ Ethnicity and Gender
Overall Costs
We examined three factors that impact submitted hospitalization costs: 1) number of co-morbidities and Charlson Comorbidity Index; 2) number of admissions; and 3) length of hospital stay (in days). We first examined cost differences for the total 2007 and 2010 samples (Table 5, It may be noted here that more than 50% of the readmissions and the total costs for the year included the costs for HF alone. Thus, the higher total costs of the year reflect all cost factors including the number of readmissions (more than 2), number of co-morbidities (more than 3), and length of hospital stay (14+ days; Table 5 , columns 4, 8) .
Costs by Race/Ethnicity and Gender
Submitted costs also varied significantly by race/ethnicity and by gender ( (Table  5 , columns 1-3, 5-7). Similar gender differences also emerged whereby higher cost for both HF alone and the total cost for the year existed for males compared with females (Table  5 , columns 9-10). These data suggest that higher cost among males and Blacks reflected greater severity of co-morbidities (see Charlson Index of condition severity score of 3.58 and 3.8, respectively), resulting in more services and longer hospitalization compared with other groups. 
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Costs by Age
Since previous studies had pointed to higher hospitalization cost for younger (aged ≤64 years) compared with older HF patients (≥65), 27 we examined cost differentials between these two groups of patients (Table  5) . Here, the cost for HF alone was 30% higher for younger patients (aged ≤64 years) compared with the older (aged ≥65 years) patients Table  5 , columns. 1-2, 5-6). Interestingly, the higher HF cost among younger Whites in 2010 ($96,735) occurred largely due to higher costs among the youngest patients (aged 20-44 years). Further, the total annual costs showed similar trends favoring Black patients as was found for HF cost alone (Table 5, columns 1-3, 5-7) .
In summary, the hospital costs (charges) varied by gender; race/ethnicity and age were higher for males and younger Black patients (aged ≤64 years). These higher costs largely reflect a higher prevalence of severe chronic conditions that afflict minority populations in general. The lower costs among the older patients (aged ≥65 years) may reflect a higher rate of mortality, which affects both the number of admissions and length of hospital stay of older patients.
dIscussIon
Our study is the first to our knowledge to examine both HF rates and costs across three racial/ethnic groups (Blacks, Hispanics, and Whites) from a large administrative dataset. We found both Black and Hispanic a. differences by ethnicity and gender significant at P<.001. # comorbid, number of comorbidities; Charlson Index, Charlson Index of Severity of Comorbid Conditions; # HF Adm., number of heart failure admissions; Total # readm., total number of readmissions; HF LOS, length of stay in days associated with heart failure; Total LOS, total days in hospital; HF Cost Alone $, hospital cost for heart failure; Total Cost $, total cost for year for any admission with at least one admission for HF; M, mean; SD, standard deviation.
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HF patients were younger (aged 64 and 69 years, respectively) than their White peers (aged 76 years). This age finding supports previously reported lower age of minority HF patients compared with Whites. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] 28 Further, we noted a decline of 7.7% in California HF rates (284.7 in 2007; 262. 8 in 2010 ). This decline is consistent with previous reports of decline in HF hospitalization. 6, 10 Interestingly, while hospitalization for HF declined in California, the decline for Blacks was smaller (5.43%) compared with Whites (7.88%) and Hispanics (7.04%). The burden of HF for Blacks in California has remained high since Alexander and colleagues 15 reported their findings in 1999. Now it appears worse for Blacks (aged ≤54 years) whose HF rates in California were more than six times (6:1) higher compared with same age Whites. In sum, for Blacks, the burden of HF starts at an early age, and it remains higher (45% to 50% higher) in older Blacks than Whites. These findings are consistent with those previously reported, [28] [29] [30] calling for proven preventive programs to focus on minority groups who are at greater risk for HF starting at younger ages. 6 We examined several clinical factors and found five factors, namely coronary heart disease (CHD), chronic kidney disease (CKD), atrial fibrillation (AFib), chronic obstructive pulmonary disease (COPD), and hypertension (HTN), as significant predictors of HF (Table 3) . Hypertension, which is a precursor of HF (see the 20-year follow-up of Framingham study), 31 existed in more than 80% of patients across all three groups and it started at an early age (35-40 years) . Given the higher prevalence of hypertension (>85% in our samples), it is not surprising to find higher prevalence of kidney disease in stages-III-V. The association of hypertension with CKD was especially noticeable among Blacks where kidney damage started at an early age (aged 35-44 years) and became progressively worse with increasing age (Table 4) . Similarly, diabetes, which existed in almost half of our patients (highest among Hispanics), had a strong contributory role, not only in HF but also in kidney dysfunction and other cardiovascular events such as heart attacks and stroke. 32, 33 With regard to hospitalization costs of HF patients, two comments need to be acknowledged. First, reported hospital costs for HF vary considerably depending on whether studies used regional, state, Medicare, or private insurance data. Secondly, while some studies reported Medicare costs (for elderly patients only), others focused on reimbursed cost, and still others have reported hospital charges for patients aged 18-64. 34 The average Medicare hospitalization cost for HF in 2008 was estimated at $10,000. 35 This cost is much lower than the cost reported for HF patients aged 18-64 years ($23,077), 34 6, 27 ministrative and other costs that are generally higher in California compared with other states. However, given the high cost of living on the West coast, one would expect that the hos-California HF by Race/Ethnicity and Gender -Husaini et al pital charges would be similar across gender and racial/ethnic groups in the California samples. Nonetheless, this was not the case. The higher costs among males and Blacks, compared with other groups, may have occurred due in part to the greater number of complex co-morbidities, which required more readmissions and longer hospitalization for Blacks. The higher costs for Blacks compared with Whites in California are similar to those reported for Black HF patients in Tennessee. 23 In addition to complexity of medical conditions, the higher costs among minority patients may also occur due to several other factors such as: 1) low health literacy/ lower recognition of disease symptoms; 2) poor access to health care providers; 3) distrust of providers; 4) patients' perceived neglect by the providers resulting in longer waiting time; and 5) lower referral to specialists for treatment. [37] [38] [39] [40] [41] [42] Such factors, affecting minority patients in all age categories, require further research as they may affect hospitalization costs.
The clinical significance of our findings is two-fold: 1) that Blacks and Hispanics are more likely than Whites to manifest cardiovascular diseases (eg, hypertension, diabetes, CHD) at an early age (aged 30-40 years); 43 and 2) from a health equity perspective, proven clinical/preventive programs should be implemented on younger minority groups to test their ability to reduce morbidity, mortality, and health care cost associated with HF.
6, 27
Limitations
Our findings are limited, in part, since hospital discharge files (HDDS) do not include patients from Veterans Affairs hospitals (VA) or patients from mental institutions. Further, the HDDS data are administrative files, which do not provide reimbursed costs. Moreover, these files do not provide data pertaining to patients' marital status, education or annual income. No clinical data are provided regarding medications used, tests performed, test results, severity or duration of illness or symptom indices used in arriving at clinical judgments/ diagnoses. For the sake of maintaining confidentiality of records, patients' assigned identification numbers change every year and hence it is not possible to follow a patient in the hospital discharge data beyond a given year. Since these potential confounding factors might affect the magnitude of observed racial/ethnic differences, there is a need for caution in interpreting the results. Even though there are some limitations as pointed above, the data remain robust and support the hypothesis that minorities and gender should be an area of focused research. Despite these limitations, however, we believe the present data provide useful insights about the impact of gender and race/ethnicity and age on hospitalization and costs of HF in California that may have application nationally.
conclusIon
We found HF rates have declined in California but they remain higher among males and Blacks compared with Whites and Hispanics. These higher rates for males, and particularly Black males, represent a higher prevalence of comorbidities, which become manifest at younger ages and which may contribute progressively to more readmissions and longer hospitalizations. These findings call for renewed emphasis on aggressive prevention, treatment and control of HF and related risk factors in these at-risk young and middle-aged groups of vulnerable populations. Future research is needed to determine whether hospitalizations for HF can be reduced among minority individuals through increased access to providers, or by implementing proven preventive programs relative to comorbidities (such as hypertension, diabetes) among atrisk young and middle-aged groups of vulnerable populations to reduce subsequent hospitalization for HF.
